11/20/2024
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:01 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:57 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:50 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
8:13 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:23 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/10/2024
3:44 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:29 AM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:21 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
8:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:26 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:53 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:57 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
4:27 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:30 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:12 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
6:07 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:41 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:37 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:57 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:38 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:58 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
5:56 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
6:11 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:46 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:37 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:23 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:51 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:21 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
6:34 AM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
5:08 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:35 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
6:54 PM | ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:58 PM | ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:59 PM | ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
7:02 PM | ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
7:03 PM | ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:45 PM | ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:14 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Download Our Tesla Ebook For Free (Ad) Like many of you, we here at the TradingPub are bullish on Tesla long term.
We believe the company will continue to be a leader in technology, EVs and A.I.
We also believe it’s share price will be rewarded in a big way…
In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. |
05/21/2024
4:21 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:01 PM | ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:05 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:50 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
4:02 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
4:02 PM | ANI Pharmaceuticals (Subject)
TANNENBAUM RENEE P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
3:59 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
6:47 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
4:25 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:09 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
5:26 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:43 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
3:50 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:33 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:19 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:41 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
8:33 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
5:28 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
8:12 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
8:13 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
8:53 PM | ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2024
3:42 PM | ANI Pharmaceuticals (Filer)
| Form ARS | |
04/02/2024
5:59 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:17 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:09 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
6:30 AM | ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
| Form SC 13D/A | |
03/13/2024
3:44 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:48 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:07 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:58 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
5:39 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:43 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:25 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
8:42 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:21 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:11 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:16 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:58 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
4:31 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:24 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:20 PM | ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:18 PM | ANI Pharmaceuticals (Subject)
Pera Antonio R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:09 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:12 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:18 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:55 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:22 AM | ANI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
2024 Election Year Stocks: Uncover Hidden Gems! (Ad) In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. |
02/29/2024
5:58 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:47 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:50 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:53 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:34 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:38 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:26 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:05 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
